Key Market Indicators
Sales of analgesic medicines in New Zealand are set to hit $9.6 million by 2026. In 2021, the market was worth $11.55 million, dropping at an average rate of 2.9% each year. Since 1998, the New Zealand market has declined by 3.4% annually. In 2021, it came in at number 23 in the rankings. Luxembourg led the way with $11.55 million in sales, followed by Spain, Canada, and Italy in the next three places.
